Cladribine (MAVENCLAD®) clinical trials

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

This study is testing a new use for a drug called Cladribine (Mavenclad) for people with advanced Multiple Sclerosis (MS). We want to see if it can slow down MS progression and improve quality of life.